[8-K] BlueLinx Holdings Inc. Reports Material Event

Rhea-AI Filing Summary

Form 144 filed for Enova International, Inc. (ENVA) discloses a planned insider sale of common stock.

• Securities for sale: 26,310 common shares, valued at approximately $2.78 million (based on Form 144 market value), to be executed through Morgan Stanley Smith Barney LLC on or after 07/29/2025 on the NYSE.
• Ownership context: ENVA reports 25,012,613 shares outstanding; the proposed sale represents roughly 0.1 % of shares outstanding.
• Acquisition source: Shares derive from a 07/29/2025 stock-option exercise (22,872 shares, cash paid) and a 02/08/2025 restricted-stock grant (3,438 shares).
• Recent activity: The filer (identified in the filing as Steven E Cunningham) previously sold 29,750 shares on 05/02/2025 for gross proceeds of $2.79 million.

The signer affirms no undisclosed material adverse information. Form 144 is a notice only; actual sales may differ in timing, amount, or execution.

Positive

• None.

Negative

• Continued insider selling: Planned disposition of 26,310 shares (~$2.8 M) follows a 29,750-share sale earlier in the quarter, potentially viewed as a bearish signal.

Insights

Securities Analyst

TL;DR: Insider plans to sell ~$2.8 M in ENVA stock, adding to earlier $2.8 M sale; modest at 0.1 % of shares.

The filing signals continued insider selling, totalling ~56 k shares over three months. While the absolute percentage of float is small, the transactions exceed $5 million in aggregate value, and cluster sales can be interpreted as management diversifying or signaling limited near-term upside. There is no reference to material non-public information, and the sales are scheduled through a broker on the open market, suggesting standard liquidity management rather than distress. Impact on share price should be limited given ENVA’s typical daily volume, but investors may monitor for pattern continuation or larger dispositions.

false000130178700013017872025-07-292025-07-29

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 29, 2025

BlueLinx Holdings Inc.

(Exact name of registrant specified in its charter)

Delaware			001-32383			77-0627356
(State or other			(Commission			(I.R.S. Employer
jurisdiction of incorporation)			File Number)			Identification No.)

1950 Spectrum Circle, Suite 300, Marietta, GA			30067
(Address of principal executive offices)			(Zip Code)

Registrant's telephone number, including area code: (770) 953-7000

 _________________________________________________

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.01 per share			BXC			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02    Results of Operations and Financial Condition         

On July 29, 2025, BlueLinx Holdings Inc. ("BlueLinx" or "the Company”) issued a press release announcing its financial results for the fiscal second quarter ended June 28, 2025. A copy of the press release is furnished as Exhibit 99.1 hereto.

On July 30, 2025, as previously announced, BlueLinx will hold a teleconference and audio webcast to discuss its financial results from the fiscal second quarter ended June 28, 2025. A copy of supplementary materials that will be referred to in the teleconference and webcast, and which will be posted to the Company's website, is furnished as Exhibit 99.2 hereto.

The information included in this Item 2.02, as well as Exhibits 99.1 and 99.2, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.

Item 8.01     Other Events

On July 29, 2025, BlueLinx Holdings Inc. ("BlueLinx" or "the“Company”) announced that its Board of Directors approved a new stock repurchase program pursuant to which the Company may repurchase up to $50 million of its common stock (the “Repurchase Program”). Under the Repurchase Program, the Company may repurchase its common stock at any time or from time to time, without prior notice, subject to prevailing market conditions and other considerations. The Company’s repurchases may be made through a variety of methods, which may include open market purchases, privately negotiated transactions, accelerated share repurchase programs, tender offers or pursuant to a trading plan that may be adopted in accordance with the Securities and Exchange Commission Rule 10b5-1.

On July 29, 2025, the Company issued a press release to announce the Repurchase Program. A copy of the press release is furnished as Exhibit 99.3 hereto.

The information included in this Item 8.01, as well as Exhibit 99.3, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933.

Item 9.01     Financial Statements and Exhibits

(d)        Exhibits:

The following exhibits are attached with this Current Report on Form 8-K:

Exhibit No.						Exhibit Description
99.1						Press Release dated July 29, 2025 reporting financial results for fiscal first quarter ended June 28, 2025
99.2						Supplementary materials to be used during webcast conference call on June 30, 2025
99.3						Press Release dated July 29, 2025 announcing the $50 million stock repurchase program
104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						BlueLinx Holdings Inc.
						(Registrant)
Dated: July 29, 2025			By:			/s/ C. Kelly Wall
						C. Kelly Wall
						Senior Vice President, Chief Financial Officer and Treasurer

FAQ

How many ENVA shares are being sold under this Form 144?

26,310 common shares are scheduled for sale.

What is the estimated market value of the proposed ENVA sale?

The filing lists an aggregate market value of $2,781,423 for the shares.

When is the ENVA insider sale expected to occur?

The approximate sale date disclosed is 07/29/2025.

How many ENVA shares has the filer sold recently?

The filer sold 29,750 shares on 05/02/2025 for gross proceeds of $2.79 million.

What percentage of ENVA’s outstanding shares does the planned sale represent?

About 0.1 % of the 25,012,613 shares outstanding.

Which broker is handling the ENVA share sale?

Morgan Stanley Smith Barney LLC, Executive Financial Services is listed as the broker.